Related Experiment Video
Updated: Dec 22, 2025

Author Spotlight: Assessment of Mitophagy Flux in Pancreatic β-Cells Using Effective and Robust Complementary Approaches
Published on: September 15, 2023
Metabolomics and Cell Therapy in Diabetes Mellitus
Bagher Larijani1, Parisa Goodarzi2, Moloud Payab3
1Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical sciences, Tehran, Iran.
Metabolomics technology aids in understanding diabetes progression and monitoring cell therapy effectiveness. This approach helps identify metabolic changes for better diabetes management and treatment strategies.
Area of Science:
- Biochemistry
- Metabolic Disorders
- Regenerative Medicine
Background:
- Diabetes mellitus is a global metabolic epidemic with diverse complications.
- Current treatments include pharmaceutical and non-pharmaceutical approaches.
- Cell-based therapies show promise for diabetes treatment.
Purpose of the Study:
- To review the utility of metabolomics in monitoring diabetes before and after cell therapy.
- To highlight how metabolomics aids in understanding diabetes pathogenesis and treatment efficacy.
- To explore the role of OMICs approaches in cell therapy for diabetes.
Main Methods:
- Review of existing literature on metabolomics and diabetes.
- Analysis of metabolic modifications during diabetes progression.
- Integration of OMICs data (genomics, transcriptomics, proteomics, metabolomics) for cell therapy insights.
Main Results:
- Metabolomics can identify specific metabolic pathways linked to diabetes and its complications.
- Quantification of metabolites is crucial for monitoring therapeutic responses.
- Cell therapy aims to improve insulin resistance, independence, and glycemic control.
Conclusions:
- Metabolomics is an effective tool for diabetic monitoring and understanding disease mechanisms.
- Understanding metabolic profiles is key to advancing cell-based diabetes treatments.
- Integrating OMICs data enhances the potential of cell therapy for diabetes management.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...

